New Liver Disease Treatment Device Unveiled
New Liver Disease Treatment Device Unveiled
In April 2026, BD announced a significant milestone with its Liverty™ TIPS Stent Graft, a device designed to manage complications of cirrhosis and portal hypertension.
Meanwhile, innovations like miroliverELAP®—a bioengineered liver support system—are targeting acute liver failure.
Other advancements include non-invasive histotripsy for tumors and promising cell-based therapies like those explored in the MATCH trial.
It is important to distinguish between these technologies: the Liverty™ device provides mechanical support for chronic cirrhosis, while miroliverELAP® offers regenerative assistance for sudden failure.
Together, these tools represent a major leap in modern hepatology.
